SCOPUS 정보 검색 플랫폼

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

CIP2A expression is increased in prostate cancer

(3) Vaarala, Markku H a Väisänen, Marja Riitta a Ristimäki, Ari a,b

a OULU UNIVERSITY HOSPITAL (Finland)

b UNIVERSITY OF HELSINKI (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CIP2A PROTEIN; ONCOPROTEIN; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG; AUTOANTIGEN; KIAA1524 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN EXPRESSION; BLOOD; CANCER STAGING; CELL DIFFERENTIATION; CHEMISTRY; FINLAND; METABOLISM; PATHOLOGY; PROSTATE TUMOR; RISK ASSESSMENT; UPREGULATION;

AUTOANTIGENS; CELL DIFFERENTIATION; FINLAND; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RISK ASSESSMENT; UP-REGULATION;

EID: 77958046984 PISSN: None EISSN: 17569966 Source Type: Journal
DOI: 10.1186/1756-9966-29-136 Document Type: Article

Times cited : (89)

References (11)

1
- 58049186804
- Protein phosphatase 2A regulatory subunits and cancer
- 18588945
- Protein phosphatase 2A regulatory subunits and cancer. PJ Eichhorn MP Creyghton R Bernards, Biochim Biophys Acta 2009 1795 1 15 18588945
- (2009) Biochim Biophys Acta , vol.1795 , pp. 1-15
- Eichhorn, P.J.¹ Creyghton, M.P.² Bernards, R.³

2
- 34447283580
- CIP2A inhibits PP2A in human malignancies
- 10.1016/j.cell.2007.04.044. 17632056
- CIP2A inhibits PP2A in human malignancies. MR Junttila P Puustinen M Niemela R Ahola H Arnold T Bottzauw R Ala-aho C Nielsen J Ivaska Y Taya SL Lu S Lin EK Chan XJ Wang R Grenman J Kast T Kallunki R Sears VM Kahari J Westermarck, Cell 2007 130 51 62 10.1016/j.cell.2007.04.044 17632056
- (2007) Cell , vol.130 , pp. 51-62
- Junttila, M.R.¹ Puustinen, P.² Niemela, M.³ Ahola, R.⁴ Arnold, H.⁵ Bottzauw, T.⁶ Ala-Aho, R.⁷ Nielsen, C.⁸ Ivaska, J.⁹ Taya, Y.¹⁰ Lu, S.L.¹¹ Lin, S.¹² Chan, E.K.¹³ Wang, X.J.¹⁴ Grenman, R.¹⁵ Kast, J.¹⁶ Kallunki, T.¹⁷ Sears, R.¹⁸ Kahari, V.M.¹⁹ Westermarck, J.²⁰ more..

3
- 52449121851
- CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells
- 10.1158/1078-0432.CCR-07-4137. 18559589
- CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells. W Li Z Ge C Liu Z Liu M Bjorkholm J Jia D Xu, Clin Cancer Res 2008 14 3722 3728 10.1158/1078-0432.CCR-07-4137 18559589
- (2008) Clin Cancer Res , vol.14 , pp. 3722-3728
- Li, W.¹ Ge, Z.² Liu, C.³ Liu, Z.⁴ Bjorkholm, M.⁵ Jia, J.⁶ Xu, D.⁷

4
- 67449085399
- MYC-dependent regulation and prognostic role of CIP2A in gastric cancer
- 10.1093/jnci/djp103. 19470954
- MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. A Khanna C Bockelman A Hemmes MR Junttila JP Wiksten M Lundin S Junnila DJ Murphy GI Evan C Haglund J Westermarck A Ristimaki, J Natl Cancer Inst 2009 101 793 805 10.1093/jnci/djp103 19470954
- (2009) J Natl Cancer Inst , vol.101 , pp. 793-805
- Khanna, A.¹ Bockelman, C.² Hemmes, A.³ Junttila, M.R.⁴ Wiksten, J.P.⁵ Lundin, M.⁶ Junnila, S.⁷ Murphy, D.J.⁸ Evan, G.I.⁹ Haglund, C.¹⁰ Westermarck, J.¹¹ Ristimaki, A.¹²

5
- 69349102025
- CIP2A is associated with human breast cancer aggressivity
- 10.1158/1078-0432.CCR-08-3283. 19671842
- CIP2A is associated with human breast cancer aggressivity. C Come A Laine M Chanrion H Edgren E Mattila X Liu J Jonkers J Ivaska J Isola JM Darbon O Kallioniemi S Thezenas J Westermarck, Clin Cancer Res 2009 15 5092 5100 10.1158/1078-0432.CCR-08-3283 19671842
- (2009) Clin Cancer Res , vol.15 , pp. 5092-5100
- Come, C.¹ Laine, A.² Chanrion, M.³ Edgren, H.⁴ Mattila, E.⁵ Liu, X.⁶ Jonkers, J.⁷ Ivaska, J.⁸ Isola, J.⁹ Darbon, J.M.¹⁰ Kallioniemi, O.¹¹ Thezenas, S.¹² Westermarck, J.¹³

6
- 20244389381
- Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens
- 10.1002/pros.20181. 15538718
- Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens. FD Shi JY Zhang D Liu A Rearden M Elliot D Nachtsheim T Daniels CA Casiano MJ Heeb EK Chan EM Tan, Prostate 2005 63 252 258 10.1002/pros.20181 15538718
- (2005) Prostate , vol.63 , pp. 252-258
- Shi, F.D.¹ Zhang, J.Y.² Liu, D.³ Rearden, A.⁴ Elliot, M.⁵ Nachtsheim, D.⁶ Daniels, T.⁷ Casiano, C.A.⁸ Heeb, M.J.⁹ Chan, E.K.¹⁰ Tan, E.M.¹¹

7
- 0038205813
- Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era
- 10.1200/JCO.2003.01.075. 12775742
- Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era. AV D'Amico J Moul PR Carroll L Sun D Lubeck MH Chen, J Clin Oncol 2003 21 2163 2172 10.1200/JCO.2003.01.075 12775742
- (2003) J Clin Oncol , vol.21 , pp. 2163-2172
- D'Amico, A.V.¹ Moul, J.² Carroll, P.R.³ Sun, L.⁴ Lubeck, D.⁵ Chen, M.H.⁶

8
- 0037173724
- Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer
- 10.1038/sj.onc.1205625. 12118381
- Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer. L Soo Hoo JY Zhang EK Chan, Oncogene 2002 21 5006 5015 10.1038/sj.onc.1205625 12118381
- (2002) Oncogene , vol.21 , pp. 5006-5015
- Soo Hoo, L.¹ Zhang, J.Y.² Chan, E.K.³

9
- 76649101395
- Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways
- 10.1099/jmm.0.014704-0. 19959630
- Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways. D Zhao Z Liu J Ding W Li Y Sun H Yu Y Zhou J Zeng C Chen J Jia, J Med Microbiol 2010 59 259 265 10.1099/jmm.0.014704-0 19959630
- (2010) J Med Microbiol , vol.59 , pp. 259-265
- Zhao, D.¹ Liu, Z.² Ding, J.³ Li, W.⁴ Sun, Y.⁵ Yu, H.⁶ Zhou, Y.⁷ Zeng, J.⁸ Chen, C.⁹ Jia, J.¹⁰

10
- 0035496220
- The development of androgen-independent prostate cancer
- 10.1038/35094009. 11900250
- The development of androgen-independent prostate cancer. BJ Feldman D Feldman, Nat Rev Cancer 2001 1 34 45 10.1038/35094009 11900250
- (2001) Nat Rev Cancer , vol.1 , pp. 34-45
- Feldman, B.J.¹ Feldman, D.²

11
- 36248973171
- The role of Src in prostate cancer
- 10.1093/annonc/mdm086. 17426060
- The role of Src in prostate cancer. K Fizazi, Ann Oncol 2007 18 1765 1773 10.1093/annonc/mdm086 17426060
- (2007) Ann Oncol , vol.18 , pp. 1765-1773
- Fizazi, K.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.